Clovis on SPi NewsFollow our SPi News RSS Feed for clovis

Featured clovis News

[27 Aug 2018] Recent Analysis Shows KalVista Pharmaceuticals, IZEA, Sonic Automotive, Catabasis Pharmaceuticals, ANI Pharmaceuticals, and Clovis Oncology Market Influences — Renewed Outlook, Key Drivers of Growth

[21 Aug 2018] Playa Lakes Joint Venture and the City of Clovis, NM, Form Nontraditional Partnership to Support Municipal Water and Provide Bird Habitat

[26 Jun 2018] Analysis: Positioning to Benefit within PBF Energy, Callaway Golf, Total System Services, Comcast, The Cheesecake Factory, and Clovis Oncology — Research Highlights Growth, Revenue, and Consolidated Results

[04 Jun 2018] Clovis Oncology and Immunomedics Announce Planned Clinical Collaboration to Study Combination Therapies in Metastatic Triple-Negative Breast and Urothelial Cancers

[09 May 2018] Consolidated Research: 2018 Summary Expectations for Catalent, MGIC Investment, United Rentals, Clovis Oncology, Pure Storage, and Chipotle Mexican Grill — Fundamental Analysis, Key Performance Indications

[17 Apr 2018] Clovis Oncology Announces Pricing of Public Offerings of Convertible Senior Notes and Common Stock

[23 Mar 2018] Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe

[23 Mar 2018] CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets

[07 Mar 2018] Research Report Identifies Tapestry, Burlington Stores, GoDaddy, Clovis Oncology, Darden Restaurants, and General Cable with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

[09 Oct 2017] Clovis Oncology Submits Supplemental New Drug Application for Rucaparib as Maintenance Treatment for Patients with Platinum-Sensitive Recurrent Ovarian Cancer

[29 Sep 2017] PetSmart® Opens New Store in Clovis, N.M.

[13 Sep 2017] Clovis Oncology’s Rucaparib ARIEL3 Study Data Published in The Lancet

[19 Jun 2017] Clovis Oncology’s Rucaparib Significantly Improved Progression-Free Survival in All Ovarian Cancer Patient Populations Studied in Phase 3 ARIEL3 Maintenance Treatment Trial

[14 Feb 2017] Update in Lawsuit for Investors in shares of Clovis Oncology Inc (NASDAQ:CLVS) announced by Shareholders Foundation

[12 Apr 2016] Trading of Clovis Oncology, Inc. Common Stock Halted

[21 Mar 2016] Fitch Affirms Clovis USD, CA at 'AA+'; Outlook Stable

[14 Jan 2016] INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Clovis Oncology, Inc. of Filing of Class Action Lawsuit and Lead Plaintiff Deadline of January 18, 2016 – CLVS

[08 Jan 2016] EQUITY NOTICE: Rosen Law Firm Reminds Clovis Oncology, Inc. Investors of Important January 19, 2016 Deadline in Class Action Filed by Firm – CLVS

[21 Dec 2015] SECURITIES FRAUD REMINDER: The Law Firm of Andrews & Springer LLC Reminds Clovis Oncology, Inc. Shareholders of Important January 19, 2016 Deadline in the Class Action- CLVS

[17 Dec 2015] Caleb Kelly of Clovis West High School Wins National High School Butkus Award(R)

[10 Dec 2015] Clovis Oncology, Inc. Shareholder Alert: Kessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Against Clovis Oncology, Inc. -- CLVS

[09 Dec 2015] Levi & Korsinsky, LLP Reminds Clovis Oncology, Inc. Shareholders of Filing of Class Action Lawsuit and Lead Plaintiff Deadline of January 18, 2016 – CLVS

[01 Dec 2015] Levi & Korsinsky, LLP Announces Filing of a Class Action Lawsuit on Behalf of Shareholders of Clovis Oncology, Inc. and a Lead Plaintiff Deadline of January 18, 2016 -- CLVS

[20 Nov 2015] Levi & Korsinsky, LLP Files Class Action Lawsuit on Behalf of Shareholders of Clovis Oncology, Inc. and Announces Lead Plaintiff Deadline of January 18, 2016 – CLVS

[17 Nov 2015] Recover Losses: Ademi & O’Reilly, LLP Investigates Possible Securities Fraud of Clovis Oncology, Inc.

[16 Dec 2014] Eastmain Resources Inc.: Clearwater Project Drilling at Clovis Lake Intersects Quartz Tourmaline Veins

[08 Jul 2014] Patient Enrollments, Board Appointments, Acquisitions, and Technical Updates - Analyst Notes on Questcor, Synta, Clovis, Alnylam and Intrexon

[18 Jun 2014] Critical Alerts For NTELOS, WebMD, Clovis Oncology, Vodafone, and Procter & Gamble Released By InvestorsObserver

[16 Jun 2014] Clinical Trial Results, Milestone Payments, New Board Members, and Executive Appointments - Analyst Notes on Cubist, Clovis, Ligand, Bio-Techne and Repligen

[12 Jun 2014] The Zacks Analyst Blog Highlights:Clovis, Biogen, Halozyme, Ariad and Chart Industries

Still looking?

Type in your search term below and click Enter

World News from SPi

Sector Publishing Intelligence [SPi'] publishes financial news from around the world FAST. For breaking news announcements from companies, blogs and commentators, SPi provides up to the minute, integrated news on all aspects of financial markets and financial services.

The SPi Financial News Search gets results from our extensive news archives containing 10’s of thousands of news reports. Intelligent cross referencing of stories and background gives readers and researchers highly relevant related information about topics and businesses in the finance sector.

Trending financial topics highlight the most recent themes in the news. Thousands of financial topics can be followed using RSS, or join hundreds of SPis Financial News followers on Twitter for instant news as soon as it’s published on SPi. @SPiFinancialSvc

SPi's extensive database of corporate information shows company details alongside breaking corporate news from the world’s largest news providers.

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us